National Cancer Registration and Analysis Service

National Cancer Registration and Analysis Service
Name	National Cancer Registration and Analysis Service
Formation	2013
Predecessor	National Cancer Intelligence Network
Type	Agency
Status	Active
Purpose	Cancer registration and analysis
Headquarters	England
Region served	United Kingdom
Parent organisation	Public Health England

National Cancer Registration and Analysis Service is the principal cancer registry and analytical unit within England tasked with systematic collection, curation and analysis of cancer incidence, survival and treatment data. It operates alongside institutions such as NHS England, Healthcare Quality Improvement Partnership, Office for National Statistics and academic centres including University College London, University of Oxford and University of Cambridge to inform clinical practice, commissioning and population health policy. The Service supports national programmes exemplified by the National Health Service (England), National Institute for Health and Care Excellence, and collaborates with international agencies like the World Health Organization, International Agency for Research on Cancer and registries in Scotland, Wales and Northern Ireland.

History

The unit was established following reforms that consolidated cancer intelligence functions from the National Cancer Intelligence Network and related units within Public Health England and predecessor bodies of Department of Health and Social Care. Its development traces to earlier registry initiatives influenced by historical models such as the Florence Nightingale–era statistical movement and modernisation programmes driven by reports from the Calman-Hine report and advisory groups including the Cancer Outcomes Strategy. Key milestones include adoption of international coding standards from the World Health Organization and integration with datasets originating from the Hospital Episode Statistics, the Office for National Statistics death registrations, and regional tumour registries established after reviews by the Cochrane Collaboration and policy evaluations by the King's Fund.

Organisation and Governance

Governance of the Service aligns with structures in Public Health England and oversight from the Department of Health and Social Care, with strategic links to NHS England and advisory input from academic consortia at institutions such as Imperial College London, London School of Hygiene & Tropical Medicine and the University of Manchester. Operational leadership reports to boards and committees that include representatives from specialist societies including the Royal College of Physicians, Royal College of General Practitioners, Royal College of Pathologists and patient organisations like Macmillan Cancer Support and Cancer Research UK. Legal and audit functions interface with entities such as the Information Commissioner's Office and the Care Quality Commission to ensure compliance with national frameworks established by the Health and Social Care Act 2012 and other statutory instruments.

Functions and Data Collection

Primary functions encompass registration of incident malignancies, longitudinal linkage of cancer records with treatment, screening and outcomes data, and production of national statistics used by stakeholders including National Institute for Health Research, Cancer Research UK and commissioners within Clinical Commissioning Groups. Data collection draws from sources such as the NHS Digital data flows, Screening programmes for breast, cervical and bowel cancer coordinated with the NHS Cancer Screening Programmes, pathology reports from laboratories accredited by United Kingdom Accreditation Service, and mortality records from the General Register Office. Outputs include cancer incidence, stage at diagnosis, treatment modalities, survival analyses and population projections used by policy makers including the Secretary of State for Health and Social Care.

Methods and Quality Assurance

The Service applies methodological frameworks using international classifications such as the International Classification of Diseases and staging systems endorsed by bodies like the Union for International Cancer Control and the AJCC Cancer Staging Manual. Quality assurance protocols reference standards from the International Agency for Research on Cancer and involve data validation, deduplication and auditing with partners in the National Institute for Health and Care Excellence and academic groups at University of Leeds and University of Birmingham. Statistical methods incorporate survival analysis techniques propagated in literature from groups linked to The Lancet, British Medical Journal and methodological work from the Medical Research Council.

Research, Reporting and Public Health Impact

Analytical products support clinical trials run by networks such as the National Cancer Research Network and observational research by centres including Cancer Research UK Cambridge Institute and the Institute of Cancer Research. Regular reports inform national strategies, influence guidance by NICE and underpin evaluations conducted by the Health Foundation and parliamentary scrutiny in the House of Commons. The Service’s data have enabled studies published in journals such as Nature, The Lancet Oncology and BMJ Open, and inform international comparisons performed with registries participating in projects coordinated by the International Agency for Research on Cancer and the European Network of Cancer Registries.

Data Access, Privacy and Legal Framework

Access to anonymised and linked datasets is governed by legal instruments including provisions in the Health and Social Care Act 2012 and data protection regimes enforced by the Information Commissioner's Office and interpreted under frameworks influenced by the General Data Protection Regulation and subsequent UK legislation. Research access procedures require approvals from research ethics committees such as those convened by the Health Research Authority and data governance panels analogous to the Data Access Advisory Group, and applications often involve collaborations with universities like University of Glasgow, Newcastle University and Queen Mary University of London. Safeguards include secure data environments modelled on platforms used by NHS Digital and adherence to disclosure control standards promulgated by the Office for National Statistics.

Category:Cancer registries Category:Public health in England